| Volume 19 • Issue 11 |
May 29, 2019 |
|
|
|
|
 |
| |
PrEUCRISATM - NOW AVAILABLE TO ORDER
|
|
|
Pfizer Canada is pleased to announce the launch and availability of PrEUCRISATM (crisaborole ointment 2%). EUCRISA is available in 60 gram tubes. To access EUCRISA Patient Information,
CLICK HERE
|
|
|
|
 |
| |
JULUCA IS NOW REIMBURSED IN ONTARIO, QUEBEC, AND NIHB
|
|
|
ViiV Healthcare ULC is proud to announce that JULUCA (50 mg dolutegravir, 25 mg rilpivirine tablets) is now reimbursed in Ontario, Quebec, and NIHB (Non-Insured Health Benefits program).
READ MORE
|
 |
|
|
|
|
| |
PREVENTION AND TREATMENT OF IRON DEFICIENCY
|
|
|
|
| |
MANY PATIENTS DON’T KNOW ABOUT AVAILABLE NON-PRESCRIPTION OPTIONS FOR ALLERGY SYMPTOM RELIEF
|
|
|
Your patients may not be aware of ALL of the options they have to relieve bothersome allergy symptoms. It’s important for your patients to know all their non-prescription options, so they can choose a product that can manage their symptoms.
READ MORE
|
 |
|
|
|
|
